TR199802769T2 - Topical composition containing a combination of terpenoid compounds and antihistamine compounds. - Google Patents

Topical composition containing a combination of terpenoid compounds and antihistamine compounds.

Info

Publication number
TR199802769T2
TR199802769T2 TR1998/02769T TR9802769T TR199802769T2 TR 199802769 T2 TR199802769 T2 TR 199802769T2 TR 1998/02769 T TR1998/02769 T TR 1998/02769T TR 9802769 T TR9802769 T TR 9802769T TR 199802769 T2 TR199802769 T2 TR 199802769T2
Authority
TR
Turkey
Prior art keywords
compounds
antihistamine
combination
terpenoid
composition containing
Prior art date
Application number
TR1998/02769T
Other languages
Turkish (tr)
Inventor
Tschollar Werner
Schmid Beat
Original Assignee
Novartis Consumer Health S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Consumer Health S.A. filed Critical Novartis Consumer Health S.A.
Publication of TR199802769T2 publication Critical patent/TR199802769T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Bulus, alerjik ve iltahabik deri hastaliklarinin tedavisi için bir terpenoid bilesik ile bir antihistaminik bilesigin bir karisimini ihtiva eden topikal eczasal bilesimlere oldugu kadar bir terpenoid bilesik (bir topikal ilacin imali için) ile kombinasyondaki bir antihistaminik bilesigin topikal kullanimina iliskindir.The invention relates to the topical use of an antihistamine compound in combination with a terpenoid compound (for the manufacture of a topical drug) as well as topical pharmaceutical compositions containing a mixture of a terpenoid compound and an antihistamine compound for the treatment of allergic and inflammatory skin diseases.

TR1998/02769T 1996-07-02 1997-07-01 Topical composition containing a combination of terpenoid compounds and antihistamine compounds. TR199802769T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96810436 1996-07-02

Publications (1)

Publication Number Publication Date
TR199802769T2 true TR199802769T2 (en) 1999-04-21

Family

ID=8225640

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/02769T TR199802769T2 (en) 1996-07-02 1997-07-01 Topical composition containing a combination of terpenoid compounds and antihistamine compounds.

Country Status (7)

Country Link
EP (1) EP0910410A1 (en)
JP (1) JP2000515498A (en)
AU (1) AU3440697A (en)
CA (1) CA2258513A1 (en)
TR (1) TR199802769T2 (en)
WO (1) WO1998000168A1 (en)
ZA (1) ZA975902B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1073738T3 (en) * 1998-04-21 2005-01-24 Max Planck Gesellschaft Human K + ion channel and therapeutic applications thereof
DK1094781T3 (en) * 1998-07-07 2008-11-03 Transdermal Technologies Inc Preparations for rapid and non-irritating transdermal administration of pharmaceutically active agents and methods for formulating such preparations and administration thereof
US6284802B1 (en) 1999-04-19 2001-09-04 The Procter & Gamble Company Methods for regulating the condition of mammalian keratinous tissue
DE60012610T2 (en) 1999-04-22 2005-08-04 Shiseido Co. Ltd. Selective antibacterial compositions
ATE421872T1 (en) * 2000-05-09 2009-02-15 Unilever Nv COSMETIC SKINCARE COMPOSITIONS CONTAINING PULEGON
WO2002045718A1 (en) * 2000-12-08 2002-06-13 Institut Pasteur De Lille Use of active compounds capable of modulating the intracellular pathway triggered by the dp receptor in langerhans cells
AU2002310237A1 (en) * 2001-05-31 2002-12-09 Galileo Laboratories, Inc. Sponge-derived terpenoids and methods of use
US6720423B2 (en) 2002-04-30 2004-04-13 Allergan, Inc. Dihydrobenzofuran and dihydrobenzothiophene 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors
JP4614638B2 (en) * 2002-06-07 2011-01-19 第一三共株式会社 Analgesic composition
US20060165637A1 (en) * 2003-06-17 2006-07-27 Vollhardt Jurgen H Topical agent containing phytanic acid or a derivative thereof
GB0417909D0 (en) * 2004-08-11 2004-09-15 Novartis Consumer Health Sa Drop preparations
US7288263B2 (en) * 2004-09-13 2007-10-30 Evera Laboratories, Llc Compositions and methods for treatment of skin discoloration
US20090264664A1 (en) * 2005-10-21 2009-10-22 Medrx Co., Ltd. Preparation for external application comprising salt of mast cell degranulation inhibitor having carboxyl group with organic amine
WO2007110380A1 (en) * 2006-03-25 2007-10-04 Boehringer Ingelheim International Gmbh Insect bite relief preparation comprising epinastine
US20090136430A1 (en) * 2007-11-27 2009-05-28 Dugger Harry A Antihistamine/Corticosteroid preparations for the treatment of atopic dermatitis
CN101390830B (en) * 2008-11-12 2011-05-18 常州市第四制药厂有限公司 Anarexol cream and preparation method thereof
JP5912238B2 (en) * 2010-09-30 2016-04-27 小林製薬株式会社 Emulsified composition
ES2598753T3 (en) 2012-11-27 2017-01-30 Eduardo Cos Alfonso Pharmaceutical composition for the treatment of calcified tendinitis and / or calcified bursitis
PT2950823T (en) * 2013-02-01 2020-10-07 Ddrops Company Liquid menthol compositions
JP6537775B2 (en) * 2014-03-10 2019-07-03 小林製薬株式会社 Emulsified composition
WO2018063876A1 (en) * 2016-09-30 2018-04-05 Alpha To Omega Pharmaceutical Consultants, Inc. Transdermal and/or topical delivery systems comprising cetirizine dihydrochloride

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59122420A (en) * 1982-12-28 1984-07-14 Otsuka Pharmaceut Factory Inc Local ointment
CA1257200A (en) * 1984-03-07 1989-07-11 Roshdy Ismail Agents for the treatment and protection of the skin
JPS62205019A (en) * 1986-03-03 1987-09-09 Kao Corp Drug for external use
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
AU4058689A (en) * 1988-06-24 1990-01-12 Stephen Herman Ozonides of terpenes and their medical uses
US5057500A (en) * 1990-02-12 1991-10-15 Dermatologic Research Corporation Treatment of pruritis with esters and amides
JPH04154719A (en) * 1990-10-19 1992-05-27 Hiroshi Kikuchi Athlete's foot drug
AU1183092A (en) * 1991-02-06 1992-09-07 Guy Parent Antalgic ointment
JPH05286860A (en) * 1992-04-03 1993-11-02 Kowa Co Gel ointment
WO1994008550A1 (en) * 1992-10-09 1994-04-28 The Procter & Gamble Company Anaesthetic compositions

Also Published As

Publication number Publication date
WO1998000168A1 (en) 1998-01-08
JP2000515498A (en) 2000-11-21
CA2258513A1 (en) 1998-01-08
EP0910410A1 (en) 1999-04-28
ZA975902B (en) 1999-01-04
AU3440697A (en) 1998-01-21

Similar Documents

Publication Publication Date Title
TR199802769T2 (en) Topical composition containing a combination of terpenoid compounds and antihistamine compounds.
ATE452129T1 (en) N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES
ES2168737T3 (en) INHIBITORS OF NITRICO SINTASA OXIDE.
HUP0102521A2 (en) Antitumor agents comprising a stilbene derivative and a platinum coordination compound
IS4073A (en) New multifunctional drug for increased resistance
BR9911482A (en) Compound, pharmaceutical composition, use of the compound, and, processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound
TR200103233T2 (en) New drug compositions on the basis of anticholinergic compounds and ß-mimetics.
BR9911488A (en) Compound, use of it, pharmaceutical composition, and processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound
BR0108678A (en) New compounds
EA200201271A1 (en) INHIBITORS 11-BETA-HYDROXYSTEROID DEGYDROGENASE TYPE 1
ES2063073T3 (en) KNOWN AND NEW SELECTED ARYLMETHYLENE DERIVATIVES OF THIAZOLIDINONES, IMIDAZOLIDINONES AND OXAZOLIDINONES USEFUL AS ANTI-ALLERGIC AGENTS AND ANTI-INFLAMMATORY AGENTS.
BR9712523A (en) New heterocyclyl-substituted pyrazole derivatives
SE9504661D0 (en) New compounds
AR012172A2 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING ANALOGS OF LACTACISTIN AND USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
BR9406363A (en) Pharmaceutical composition process for the preparation of the same use and process for the treatment of diseases related to gastric acid
MX9301136A (en) COMPOSITIONS CONTAINING PSYLLIUM.
ATE243196T1 (en) PIPERIDINE AND PYRROLIDINE
CO5160321A1 (en) NEW COMPOSITIONS OF TIPRANAVIR AND RITONAVIR
BR0209645A (en) Oxazole and furopyrimidines and their use as medicines
DE69713300T2 (en) BENZOPYRANE DERIVATIVES WITH LEUKOTRIA-ANTAGONISTIC EFFECT
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
TR200000737T2 (en) Substituted chroma derivatives.
TR200000153T2 (en) 6-azauracil derivatives that inhibit il-5.
ATE134294T1 (en) COMPOSITION WITH PSYLLIUM
MX9204613A (en) ORGANIC NITRATES, PROCEDURES FOR ITS PREPARATION AND USE IN THE TREATMENT OF CARDIOVASCULAR DISEASES